These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6352863)

  • 1. The effect of proteolytic cleavage of La Crosse virus G1 glycoprotein on antibody neutralization.
    Kingsford L; Hill DW
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2147-56. PubMed ID: 6352863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus.
    Kingsford L; Ishizawa LD; Hill DW
    Virology; 1983 Sep; 129(2):443-55. PubMed ID: 6194614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme processing of La Crosse virus glycoprotein G1: a bunyavirus-vector infection model.
    Ludwig GV; Christensen BM; Yuill TM; Schultz KT
    Virology; 1989 Jul; 171(1):108-13. PubMed ID: 2662577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against La Crosse virus.
    Grady LJ; Srihongse S; Grayson MA; Deibel R
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1699-704. PubMed ID: 6192204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced neutralization of La Crosse virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein.
    Kingsford L
    Virology; 1984 Jul; 136(2):265-73. PubMed ID: 6205500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for three separate antigenic sites on the G1 protein of La Crosse Virus.
    Grady LJ; Sanders ML; Campbell WP
    Virology; 1983 Apr; 126(1):395-7. PubMed ID: 6189289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies specific for the G1 glycoprotein of La Crosse virus that react with other California serogroup viruses.
    Kingsford L; Boucquey KH
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():523-30. PubMed ID: 2179465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity.
    Grady LJ; Kinch W
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2773-6. PubMed ID: 4067586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies directed against the envelope glycoproteins of La Crosse virus.
    Ludwig GV; Israel BA; Christensen BM; Yuill TM; Schultz KT
    Microb Pathog; 1991 Dec; 11(6):411-21. PubMed ID: 1795631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitopes of the G1 glycoprotein of La Crosse virus form overlapping clusters within a single antigenic site.
    Najjar JA; Gentsch JR; Nathanson N; Gonzalez-Scarano F
    Virology; 1985 Jul; 144(2):426-32. PubMed ID: 2414920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and biological function of La Crosse G1 glycoprotein.
    Kingsford L
    Prog Clin Biol Res; 1983; 123():157-66. PubMed ID: 6191342
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid diagnosis of La Crosse virus infections: evaluation of serologic and antigen detection techniques for the clinically relevant diagnosis of La Crosse encephalitis.
    Beaty BJ; Jamnback TL; Hildreth SW; Brown KL
    Prog Clin Biol Res; 1983; 123():293-302. PubMed ID: 6346337
    [No Abstract]   [Full Text] [Related]  

  • 13. Production and use of a hemagglutinin for detecting antibody to Jamestown Canyon virus.
    Grimstad PR; Artsob H; Karabatsos N; Calisher CH
    J Clin Microbiol; 1987 Aug; 25(8):1557-9. PubMed ID: 3624448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serodiagnosis of La Crosse virus infections in humans.
    Calisher CH; Bailey RE
    J Clin Microbiol; 1981 Feb; 13(2):344-50. PubMed ID: 7204551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for the G1 protein of California encephalitis virus in infection in vitro and in vivo.
    Hacker JK; Volkman LE; Hardy JL
    Virology; 1995 Feb; 206(2):945-53. PubMed ID: 7531919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of La Crosse virus glycoproteins in attachment of virus to host cells.
    Ludwig GV; Israel BA; Christensen BM; Yuill TM; Schultz KT
    Virology; 1991 Apr; 181(2):564-71. PubMed ID: 1673039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of La Crosse virus replication by monensin, monovalent ionophore.
    Cash P
    J Gen Virol; 1982 Mar; 59(Pt 1):193-6. PubMed ID: 7069403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.
    Pekosz A; Griot C; Stillmock K; Nathanson N; Gonzalez-Scarano F
    J Virol; 1995 Jun; 69(6):3475-81. PubMed ID: 7745694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus.
    Sundin DR; Beaty BJ; Nathanson N; Gonzalez-Scarano F
    Science; 1987 Jan; 235(4788):591-3. PubMed ID: 3810159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The virus particle nucleic acids and proteins of four bunyaviruses.
    Gentsch J; Bishop DH; Obijeski JF
    J Gen Virol; 1977 Feb; 34(2):257-68. PubMed ID: 839199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.